Abstract

Gait impairments in Alzheimer’s disease (AD) result from structural and functional deficiencies that generate limitations in the performance of activities and restrictions in individual’s biopsychosocial participation. In a translational way, we have used the conceptual framework proposed by the International Classification of Disability and Health Functioning (ICF) to classify and describe the functioning and disability on gait and exploratory activity in the 3xTg-AD animal model. We developed a behavioral observation method that allows us to differentiate qualitative parameters of psychomotor performance in animals’ gait, similar to the behavioral patterns observed in humans. The functional psychomotor evaluation allows measuring various dimensions of gait and exploratory activity at different stages of disease progression in dichotomy with aging. We included male 3xTg-AD mice and their non-transgenic counterpart (NTg) of 6, 12, and 16 months of age (n = 45). Here, we present the preliminary results. The 3xTg-AD mice show more significant functional impairment in gait and exploratory activity quantitative variables. The presence of movement limitations and muscle weakness mark the functional decline related to the disease severity stages that intensify with increasing age. Motor performance in 3xTg-AD is accompanied by a series of bizarre behaviors that interfere with the trajectory, which allows us to infer poor neurological control. Additionally, signs of physical frailty accompany the functional deterioration of these animals. The use of the ICF as a conceptual framework allows the functional status to be described, facilitating its interpretation and application in the rehabilitation of people with AD.

Highlights

  • Introduction published maps and institutional affilAlzheimer’s disease (AD) is a complex and heterogeneous disorder with a distinctive clinical presentation [1,2]

  • We developed a method for the characterization of qualitative parameters of psychomotor performance in the gait pattern of male mice in different stages of the disease: initial (6 months), advanced beta (12 months), and advanced beta-tau (16 months) in contrast with normal aging

  • Mouse model in different stages of the disease and its counterpart non-transgenic counterpart (NTg) of normal aging, according to the analysis and quantification parameters proposed by ICF

Read more

Summary

Introduction

Introduction published maps and institutional affilAlzheimer’s disease (AD) is a complex and heterogeneous disorder with a distinctive clinical presentation [1,2]. The main signs of AD are cognitive impairment, motor disorders such as bradykinesia, rigidity, and gait disorders are of great importance due to the functional limitations and impairments that they cause during the disease [4,5]. In this sense, different studies have demonstrated different motor alterations during the last two decades, those associated with walking and displacement [6,7,8]. This gait pattern is similar to that observed in the aging; there may be decrease in speed, stride length, and postural stability of gait, which is manifested in static and dynamic balance, with a widened base of support [11]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call